Defining a new era of oligonucleotides

Defining a new era of oligonucleotides

Press Releases

Press Releases

  • Apr 05, 2018
    Wave Life Sciences to Present at Upcoming Investor Conferences

    CAMBRIDGE, Mass. , April 05, 2018 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ:WVE), a biotechnology company focused on delivering transformational therapies for patients with serious, genetically-defined diseases, today announced that Paul Bolno , MD, MBA, President and Chief Executive





  • Events and Presentation